To allay FTC concerns, Bristol-Myers to sell Celgene psoriasis treatment
June 24, 2019 at 10:04 AM EDT
The sale of Celgene's Otezla will "allow the transaction to close on a timely basis," Bristol-Myers Squibb said.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|